Cytotoxicity, mutagenicity and genotoxicity of electronic cigarettes emission aerosols compared to cigarette smoke: the REPLICA project.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 10 2023
Historique:
received: 24 05 2023
accepted: 10 10 2023
medline: 1 11 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: epublish

Résumé

Concerns have recently increased that the integrity of some scientific research is questionable due to the inability to reproduce the claimed results of some experiments and thereby confirm that the original researcher's conclusions were justified. This phenomenon has been described as 'reproducibility crisis' and affects various fields from medicine to basic applied sciences. In this context, the REPLICA project aims to replicate previously conducted in vitro studies on the toxicity of cigarette smoke and e-cigarette aerosol, sometimes adding experiments or conditions where necessary, in order to verify the robustness and replicability of the data. In this work the REPLICA Team replicated biological and toxicological assessment published by Rudd and colleagues in 2020. As in the original paper, we performed Neutral Red Uptake (NRU) assay for the evaluation of cytotoxicity, Ames test for the evaluation of mutagenesis and In Vitro Micronuclei (IVMN) assay for the evaluation of genotoxicity on cells treated with cigarette smoke or e-cigarette aerosol. The results showed high cytotoxicity, mutagenicity and genotoxicity induced by cigarette smoke, but slight or no cytotoxic, mutagenic and genotoxic effects induced by the e-cigarette aerosol. Although the two studies presented some methodological differences, the findings supported those previously presented by Rudd and colleagues.

Identifiants

pubmed: 37903810
doi: 10.1038/s41598-023-44626-1
pii: 10.1038/s41598-023-44626-1
pmc: PMC10616076
doi:

Substances chimiques

Mutagens 0
Aerosols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17859

Investigateurs

Giovanni Li Volti (G)
Massimo Caruso (M)
Rosalia Emma (R)
Antonio Giordano (A)
Ang Sun (A)
Vladislav Volarevic (V)
Ronny Lesmana (R)
Konstantinos Poulas (K)
Alfio Distefano (A)
Konstantinos Partsinevelos (K)
Roberta Pulvirenti (R)
Aurora Costa (A)
Aleksandar Arsenijevic (A)
Melisa I Barliana (MI)
Konstantinos Mesiakaris (K)
Najwa Albalushi (N)
Chiara Giardina (C)
Salvatore Furnari (S)

Informations de copyright

© 2023. Springer Nature Limited.

Références

Toxicol Lett. 1985 Feb-Mar;24(2-3):119-24
pubmed: 3983963
Regul Toxicol Pharmacol. 2021 Oct;125:105018
pubmed: 34314750
Toxicol In Vitro. 2015 Oct;29(7):1720-8
pubmed: 26096598
Mutat Res Genet Toxicol Environ Mutagen. 2016 Jun;803-804:13-21
pubmed: 27265375
Toxicol Mech Methods. 2016 Jul;26(6):477-491
pubmed: 27690199
Regul Toxicol Pharmacol. 2019 Apr;103:314-324
pubmed: 30721718
Toxicol Sci. 2021 Jan 28;179(2):220-228
pubmed: 33226417
Nat Protoc. 2008;3(7):1125-31
pubmed: 18600217
Food Chem Toxicol. 2019 Oct;132:110546
pubmed: 31163219
Regul Toxicol Pharmacol. 2018 Mar;93:71-83
pubmed: 29080850
Mutat Res Genet Toxicol Environ Mutagen. 2019 Dec;848:403074
pubmed: 31708073
Mutat Res Genet Toxicol Environ Mutagen. 2016 Dec;812:29-38
pubmed: 27908385
Respir Res. 2021 May 18;22(1):151
pubmed: 34006276
Front Pharmacol. 2021 Mar 30;12:652102
pubmed: 33859566
Nature. 2016 May 25;533(7604):452-4
pubmed: 27225100
Sci Adv. 2021 May 21;7(21):
pubmed: 34020944
Toxicol Rep. 2019 Feb 25;6:222-231
pubmed: 30886823
Sci Rep. 2021 Dec 17;11(1):24182
pubmed: 34921164
Food Chem Toxicol. 2006 May;44(5):724-38
pubmed: 16324776
Drug Test Anal. 2023 Oct;15(10):1145-1155
pubmed: 35434934
Food Chem Toxicol. 2021 Jan;147:111864
pubmed: 33217530
Int J Mol Sci. 2020 Oct 31;21(21):
pubmed: 33142951
Toxicol Rep. 2018 Apr 12;5:542-551
pubmed: 29854624
Toxicol Lett. 2017 Jan 4;265:170-178
pubmed: 27965004
Mutat Res. 1983 May;113(3-4):173-215
pubmed: 6341825

Auteurs

Rosalia Emma (R)

Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Virginia Fuochi (V)

Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Alfio Distefano (A)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Konstantinos Partsinevelos (K)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Sonja Rust (S)

ECLAT Srl, Spin Off of the University of Catania, Via. S Sofia 89, 95123, Catania, Italy.

Fahad Zadjali (F)

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, P.C 123, P.O. Box 35, Khodh, Oman.

Mohammed Al Tobi (M)

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, P.C 123, P.O. Box 35, Khodh, Oman.

Razan Zadjali (R)

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, P.C 123, P.O. Box 35, Khodh, Oman.

Zaina Alharthi (Z)

Department of Clinical Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, P.C 123, P.O. Box 35, Khodh, Oman.

Roberta Pulvirenti (R)

Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Pio Maria Furneri (PM)

Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Riccardo Polosa (R)

Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
ECLAT Srl, Spin Off of the University of Catania, Via. S Sofia 89, 95123, Catania, Italy.

Ang Sun (A)

Department of Biology, College of Science and Technology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, USA.

Massimo Caruso (M)

Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. mascaru@unict.it.
Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy. mascaru@unict.it.

Giovanni Li Volti (G)

Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.
Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 97, 95123, Catania, Italy.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
Humans Middle Aged Female Male Surveys and Questionnaires
Adolescent Child Female Humans Male

Classifications MeSH